StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
XBIO

Xenetic Biosciences, Inc.

XBIO Nasdaq Pharmaceutical Preparations EDGAR ↗
$2.66
+0.11 +4.31%

Key statistics

from XBRL data in SEC filings
Market cap
$6.09M
Revenue (TTM)
$3.19M
Net income (TTM)
-$2.23M
EPS (TTM)
$-1.19
P/E ratio
Dividend yield
Free cash flow
Cash
$7.35M
Total assets
$7.91M
Gross margin
52-week range
$1.90 – $13.93

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Results of operations (earnings release) May 13, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 10-K/A Fiscal year ended 2025-12-31 Apr 24, 2026 8-K Director or officer change Apr 24, 2026 8-K Results of operations (earnings release) Mar 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 12, 2026 8-K Other events Jan 9, 2026 8-K Regulation FD disclosure Dec 11, 2025 8-K Results of operations (earnings release) Nov 13, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Entered a material agreement; Other events Oct 14, 2025 8-K Results of operations (earnings release) Aug 13, 2025 10-Q Quarter ended 2025-06-30 Aug 12, 2025 8-K Results of operations (earnings release) May 14, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 10-K/A Fiscal year ended 2024-12-31 May 13, 2025 10-K/A Fiscal year ended 2024-12-31 Apr 29, 2025 8-K Changed accountants Apr 10, 2025 8-K/A AMENDMENT NO 1 Mar 19, 2025 8-K Results of operations (earnings release) Mar 19, 2025 10-K Fiscal year ended 2024-12-31 Mar 18, 2025 8-K Shareholder vote results Dec 13, 2024 8-K Results of operations (earnings release) Nov 13, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Entered a material agreement; Regulation FD disclosure Nov 7, 2024 8-K Director or officer change Oct 31, 2024 8-K Results of operations (earnings release) Aug 14, 2024 10-Q Quarter ended 2024-06-30 Aug 13, 2024 8-K Director or officer change Jun 21, 2024 8-K Director or officer change; Regulation FD disclosure May 22, 2024 8-K Results of operations (earnings release) May 10, 2024 10-Q Quarter ended 2024-03-31 May 9, 2024 10-K/A Fiscal year ended 2023-12-31 Apr 26, 2024 8-K Results of operations (earnings release) Mar 22, 2024 10-K Fiscal year ended 2023-12-31 Mar 21, 2024 8-K Regulation FD disclosure Feb 12, 2024 8-K Shareholder vote results Dec 8, 2023 8-K Results of operations (earnings release) Nov 13, 2023 10-Q Quarter ended 2023-09-30 Nov 9, 2023 8-K Results of operations (earnings release) Aug 11, 2023